|
To,
Sun Pharma Laboratories Limited
SUN House,
Mumbai.
Subject : A retrospective cross-sectional, observational survey study to analyze role of flexible
dosing of Gabapentin + Amitriptyline FDC in patients with neuropathic pain not responding to
monotherapy
In response to your letter dated ________, I agree to participate in the study as outlined by you.
I understand that:
-
You will provide me with a copy of the data collection plan and _________ DCFs.
-
All the data shared by me will be retrospective in nature.
-
The patient’s identity will not be disclosed in the DCF.
My personal details are given below for accuracy of your records.
|